Logo 1 Logo 2

Clinical Trial Details

Trial ID: L6704
Source ID: NCT01704378
Associated Drug: Biphasic Insulin Aspart
Title: Efficacy and Safety of Biphasic Insulin Aspart 30 FlexPen™ in Subjects With Type 2 Diabetes
Acronym:
Status: COMPLETED
Study Results: NO
Results:
Conditions: Diabetes|Diabetes Mellitus, Type 2
Interventions: DRUG: biphasic insulin aspart
Outcome Measures: Primary: Number of Hypoglycaemic episodes|Occurrence of adverse events | Secondary: HbA1c (glycosylated haemoglobin)|Prandial increment in blood glucose|7-point blood glucose profile
Sponsor/Collaborators: Sponsor: Novo Nordisk A/S
Gender: ALL
Age: ADULT, OLDER_ADULT
Phases: PHASE4
Enrollment: 89
Study Type: INTERVENTIONAL
Study Designs: Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Start Date: 2001-04-18
Completion Date: 2003-03-14
Results First Posted:
Last Update Posted: 2017-02-24
Locations: Novo Nordisk Investigational Site, Kotka, 48210, Finland|Novo Nordisk Investigational Site, Kuopio, 70210, Finland|Novo Nordisk Investigational Site, Lahti, 15850, Finland|Novo Nordisk Investigational Site, Gjøvik, NO-2819, Norway|Novo Nordisk Investigational Site, Horten, NO-3188, Norway|Novo Nordisk Investigational Site, Kirkenær, 2260, Norway|Novo Nordisk Investigational Site, Kongsvinger, 2212, Norway|Novo Nordisk Investigational Site, Notodden, NO-3675, Norway|Novo Nordisk Investigational Site, Falun, 791 82, Sweden|Novo Nordisk Investigational Site, Helsingborg, 254 43, Sweden|Novo Nordisk Investigational Site, Motala, 591 85, Sweden|Novo Nordisk Investigational Site, Derby, DE7 1DY, United Kingdom|Novo Nordisk Investigational Site, Edinburgh, EH16 4SA, United Kingdom|Novo Nordisk Investigational Site, Hull, HU3 2JZ, United Kingdom|Novo Nordisk Investigational Site, Liverpool, L7 8XP, United Kingdom|Novo Nordisk Investigational Site, Scarborough, YO12 6QL, United Kingdom|Novo Nordisk Investigational Site, Wirral, Merseyside, CH63 4JY, United Kingdom
URL: https://clinicaltrials.gov/show/NCT01704378

Drug ID Drug Name Type DrugBank ID Targets Category Latest Progress